Actively Recruiting
ALS Research Collaborative
Led by ALS Therapy Development Institute · Updated on 2025-03-20
2000
Participants Needed
1
Research Sites
1063 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this natural history study is to learn more about the biological and clinical aspects of amyotrophic lateral sclerosis (ALS). This study's findings will help with drug discovery, biomarker discovery, and outcome measure validation. Adults living with ALS, other motor neuron diseases (MND), a known mutation related to ALS and healthy volunteers contribute prospective and retrospective data to this study remotely. The study is sponsored and conducted by the ALS Therapy Development Institute.
CONDITIONS
Official Title
ALS Research Collaborative
Who Can Participate
Eligibility Criteria
You may qualify if you...
- 18 years of age or older
- Can communicate in written English
- Has a diagnosis of ALS/MND or is a known carrier of an ALS associated mutation
You will not qualify if you...
- Significant cognitive impairment that would prevent individual completion and understanding of the informed consent process.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
ALS Therapy Development Institute
Watertown, Massachusetts, United States, 02472
Actively Recruiting
Research Team
A
Alan S Premasiri, M.S.
CONTACT
B
Beth Levine
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here